| · Registration
exam (2)
· Pharmacist prescribing
· Agenda for change
· New contract (3)
· Retention fees (2)
· Statins
· Levothyroxine
· The Journal
Letters to the Editor
|
Statins
Misleading advertising?
From Mr I. R. MacKillop, MRPharmS
May I draw your attention to the advertisement for Johnson & Johnson
MSD’s over-the-counter statin, Zocor Heart-Pro, which appeared
in the Independent on Sunday on 7 November [and appears in The
Journal this week (pA3)]. If we are to assume that the man in the picture is
supposed to be the one saying the words in quotation marks, then something,
somewhere, is wrong. First, he has fewer chins than me, so he is not
obese, and secondly, from the condition of his skin, if he was ever in
the habit of smoking he did the smart thing years ago.
This means that the only possible reason for any pharmacist conversant
with the protocols laid down by Johnson & Johnson to supply him with
Zocor Heart-Pro is a family history of hyperlipidaemia, which is mentioned
nowhere in the quotation marks. There is a get-out clause further down
in which it makes clear that 45- to 55-year-old men have to have one
of these three additional factors for the risk to be as high as one in
seven, but how many punters read every word of an advertisement? Most,
if not all, read the headline and base their decision on that. And what
is your average 45-year-old male going to decide? That they have a one
in seven chance of getting a heart attack and they had better get some
Zocor Heart-Pro. Whereupon, if they look like the guy in the photograph
and have no hyperlipidaemia in the family they will be told by us pharmacists,
politely but firmly, to be on their way. At which point, we pharmacists
will be called unfeeling, unprofessional monsters (or worse) for refusing
to sell them the medicine they need to save their lives.
Ian MacKillop
Ilminster, Somerset
| |
CAROLINE O’DWYER, marketing manager, Johnson & Johnson.MSD,
replies:
The purpose of the man featured within the Zocor Heart-Pro
advertising is to represent someone who may benefit from being recommended
an over-the-counter
statin. Such individuals are appropriate for a recommendation if they
have a 10–15 per cent (or one in 10 to one in seven) risk of a
heart attack in the next 10 years, and can be identified by assessing
their
age and the presence of specific risk factors for heart disease. These
criteria are clearly stated within the advertising text. The advertising
also directs individuals to discuss their risk status and eligibility
for Zocor Heart-Pro with their pharmacist as a key next step.
The headline of the advertisement makes it clear that this individual
is 45 years old. Age is the major driver for cardiovascular risk:
men from the age of 45
years and women from the age of 55 years have steeply increasing risk in
the remaining decades of life. This “baseline” risk is 10–15
per cent for the male population over 55 years. However, for younger men, ie,
those
45 years and over, a further risk factor is required before the risk would
fall into this category. Although it is obvious from the visual that this individual
does not qualify as a result of being overweight, it is entirely possible that
he may qualify as a result of having a family history of early heart disease,
or alternatively that he is a smoker (current or has given up within the past
five years).
If an individual aged 45 presents without other risk factors for CHD, then
it is appropriate that a pharmacist alert the individual to the fact that
their risk level is not high enough to justify treatment with Zocor Heart-Pro,
and
encourage the individual to continue with their healthy heart lifestyle.
Rather than find the pharmacist “unfeeling” or “unprofessional monsters”,
it is more likely that the customer would be relieved to hear this advice.
In summary we believe our national press advertising campaign is a responsible
and measured attempt to increase awareness of CHD risk among the population
most likely to benefit from reducing that risk. This population is clearly
defined
within the text of the advertisement, and readers are directed to check with
a pharmacist to ensure that the product is right for them. It is also important
to note that all of our advertising material has been approved by the Medicines
and Healthcare products Regulatory Agency as being in line with the summary
of product characteristics for Zocor Heart-Pro. Furthermore the advertising
material
has also been fully reviewed by the Proprietary Association of Great Britain
for compliance with the self-medication industry’s codes of practice
for over-the-counter medicines. |
|